Page 78 - GPD-3-3

Gene & Protein in Disease Gene therapy progress for DEB

with epidermolysis bullosa. Spec Care Dentist. 2020;40(S1): 27. Wang X, Ghasri P, Amir M, et al. Topical application of
3-81. recombinant Type VII collagen incorporates into the
dermal-epidermal junction and promotes wound closure.
doi: 10.1111/scd.12511
Mol Ther. 2013;21(7):1335-1344.
18. Papanikolaou M, Onoufriadis A, Mellerio JE, et al.
Prevalence, pathophysiology and management of itch in doi: 10.1038/mt.2013.87
epidermolysis bullosa. Br J Dermatol. 2021;184(5):816-825. 28. Eichstadt S, Barriga M, Ponakala A, et al. Phase 1/2a
clinical trial of gene-corrected autologous cell therapy for
doi: 10.1111/bjd.19496
recessive dystrophic epidermolysis bullosa. JCI Insight.
19. Condorelli AG, Dellambra E, Logli E, Zambruno G, 2019;4(19):e130554.
Castiglia D. Epidermolysis bullosa-associated squamous cell doi: 10.1172/jci.insight.130554
carcinoma: From pathogenesis to therapeutic perspectives.
IJMS. 2019;20(22):5707. 29. Lwin SM, Syed F, Di WL, et al. Safety and early efficacy
outcomes for lentiviral fibroblast gene therapy in
doi: 10.3390/ijms20225707
recessive dystrophic epidermolysis bullosa. JCI Insight.
20. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. 2019;4(11):e126243.
Participation of bone marrow derived cells in cutaneous doi: 10.1172/jci.insight.126243
wound healing. J Cell Physiol. 2003;196(2):245-250.
30. Zhou D, Cutlar L, Gao Y, et al. The transition from linear
doi: 10.1002/jcp.10260 to highly branched poly(β-amino ester)s: Branching matters
21. Petrof G, Lwin SM, Martinez-Queipo M, et al. Potential of for gene delivery. Sci Adv. 2016;2(6):e1600102.
systemic allogeneic mesenchymal stromal cell therapy for doi: 10.1126/sciadv.1600102
children with recessive dystrophic epidermolysis bullosa.
J Invest Dermatol. 2015;135(9):2319-2321. 31. Zhou D, Gao Y, Aied A, et al. Highly branched poly(β-amino
ester)s for skin gene therapy. J Control Release. 2016;244:
doi: 10.1038/jid.2015.158 336-346.
22. Petrova A, Georgiadis C, Fleck RA, et al. Human doi: 10.1016/j.jconrel.2016.06.014
mesenchymal stromal cells engineered to express collagen
VII can restore anchoring fibrils in recessive dystrophic 32. Cutlar L, Zhou D, Hu X, et al. A non-viral gene therapy for
epidermolysis bullosa skin graft chimeras. J Invest Dermatol. treatment of recessive dystrophic epidermolysis bullosa. Exp
2020;140(1):121-131.e6. Dermatol. 2016;25(10):818-820.
doi: 10.1016/j.jid.2019.05.031 doi: 10.1111/exd.13054
23. Ganier C, Titeux M, Gaucher S, et al. Intradermal injection 33. Guide SV, Gonzalez ME, Bağcı IS, et al. Trial of beremagene
of bone marrow mesenchymal stromal cells corrects geperpavec (B-VEC) for dystrophic epidermolysis bullosa.
recessive dystrophic epidermolysis bullosa in a xenograft N Engl J Med. 2022;387(24):2211-2219.
model. J Invest Dermatol. 2018;138(11):2483-2486. doi: 10.1056/NEJMoa2206663
doi: 10.1016/j.jid.2018.04.028 34. Tovar Vetencourt A, Sayed-Ahmed I, Gomez J, et al. Ocular
24. Remington J, Wang X, Hou Y, et al. Injection of recombinant gene therapy in a patient with dystrophic epidermolysis
human type VII collagen corrects the disease phenotype in bullosa. N Engl J Med. 2024;390(6):530-535.
a murine model of dystrophic epidermolysis bullosa. Mol doi: 10.1056/NEJMoa2301244
Ther. 2009;17(1):26-33.
35. Goto M, Sawamura D, Nishie W, et al. Targeted skipping
doi: 10.1038/mt.2008.234 of a single exon harboring a premature termination codon
25. Gretzmeier C, Pin D, Kern JS, et al. Systemic collagen VII mutation: Implications and potential for gene correction
replacement therapy for advanced recessive dystrophic therapy for selective dystrophic epidermolysis bullosa
epidermolysis bullosa. J Invest Dermatol. 2022;142(4):1094- patients. J Invest Dermatol. 2006;126(12):2614-2620.
1102.e3. doi: 10.1038/sj.jid.5700435
doi: 10.1016/j.jid.2021.09.008 36. Bremer J, Bornert O, Nyström A, et al. Antisense
oligonucleotide-mediated exon skipping as a systemic
26. Woodley DT, Wang X, Amir M, et al. Intravenously
injected recombinant human Type VII collagen homes therapeutic approach for recessive dystrophic epidermolysis
to skin wounds and restores skin integrity of dystrophic bullosa. Mol Ther Nucleic Acids. 2016;5:e379.
epidermolysis bullosa. J Invest Dermatol. 2013;133(7): doi: 10.1038/mtna.2016.87
1910-1913.
37. Turczynski S, Titeux M, Tonasso L, Décha A, Ishida-
doi: 10.1038/jid.2013.10 Yamamoto A, Hovnanian A. Targeted exon skipping

Volume 3 Issue 3 (2024) 9 doi: 10.36922/gpd.4047